Register entry
- Registered sites
- 0
- Active NDC listings
- 10
- Live patents
- 24
- Countries
- 0
Catalogue
Drug listings by form and route
1010 active NDC listings: 10 human prescription drug. By marketing category: NDA 10.
| Dosage form | NDCs |
|---|---|
| kit | 6 |
| capsule | 4 |
| Route | NDCs |
|---|---|
| oral | 10 |
| Labeller name on the listing | NDCs |
|---|---|
| acer therapeutics inc. | 10 |
Exclusivity
Patents and exclusivities
24| Patent | Product | Covers | Expiry |
|---|---|---|---|
| 11154521 | OLPRUVAsodium phenylbutyrate | product | Oct 2036 |
| 11202767 | OLPRUVAsodium phenylbutyrate | use | Oct 2036 |
| 11433041 | OLPRUVAsodium phenylbutyrate | product | Oct 2036 |
Catalogue
Marketed products
10| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| MIPLYFFA | arimoclomol citrate | capsule, oral | 72542-124NDA |
| MIPLYFFA | arimoclomol citrate | capsule, oral | 72542-147NDA |
| MIPLYFFA | arimoclomol citrate | capsule, oral | 72542-162NDA |
| MIPLYFFA | arimoclomol citrate | capsule, oral | 72542-193NDA |
| OLPRUVA | sodium phenylbutyrate | kit, oral | 72542-200NDA |
| OLPRUVA | sodium phenylbutyrate | kit, oral | 72542-300NDA |
| OLPRUVA | sodium phenylbutyrate | kit, oral | 72542-400NDA |
| OLPRUVA | sodium phenylbutyrate | kit, oral | 72542-500NDA |
| OLPRUVA | sodium phenylbutyrate | kit, oral | 72542-600NDA |
| OLPRUVA | sodium phenylbutyrate | kit, oral | 72542-667NDA |
Compare
Other companies listing sodium phenylbutyrate
- Glenmark Pharmaceuticals Inc., USA9 sites · 383 NDC
- Rottendorf Pharma GmbH1 site · 17 NDC
- Horizon Pharmaceuticals , Inc.1 site · 12 NDC
Enquiry
Common questions
- Is Acer Therapeutics Inc. FDA approved?
- Acer Therapeutics Inc. holds no registered establishment of its own; 10 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
- What drugs does Acer Therapeutics Inc. make?
- 10 products are listed under Acer Therapeutics Inc. in the openFDA NDC Directory, most often as kit; capsule. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.